A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
A Non-interventional, Post-authorisation Safety Study of Patients Treated With Efgartigimod Alfa
This is a non-interventional, prospective, post authorization safety study. Patients with gMG who are expected to start treatment with efgartigimod at enrolment or are within their first cycle of efgartigimod at enrolment will be eligible to enroll into the efgartigimod cohort. Patients with gMG who have not been exposed to efgartigimod and for whom it is not planned to start treatment with efgartigimod at enrolment will be eligible to enroll into the non-efgartigimod cohort.
Inclusion Criteria:
Exclusion Criteria:
Clinicaltrials@argenx.com857-350-4834
San Francisco, California 94143, United States
clinicaltrials@argenx.com857-350-4834
Jacksonville Beach, Florida 32209, United States
St. Petersburg, Florida 33705, United States
O'Fallon, Illinois 62701, United States
Linz, 4021, Austria
Barcelona, 08035, Spain
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834
clinicaltrials@argenx.com857-350-4834